Isosorbide Dinitrate

Isosorbide Dinitrate

SCHEMBL8253

O=[N+]([O-])O[C@H]1CO[C@H]2[C@@H]1OC[C@H]2O[N+](=O)[O-]

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GUCY1A1GUCY1A2GUCY1B1GUCY1B2

The experimentally established mechanism targets of Isosorbide Dinitrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 1.00
MAPT P10636 1/20 0.78
BCHE P06276 6/20 0.64
GSR P00390 8/20 0.46
CA2 P00918 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isosorbide Dinitrate SCHEMBL19528695 1.00 ALDH1A1 (1.00) ALDH1A1MAPTBCHEGSRCA2
Isosorbide Dinitrate SCHEMBL9439417 1.00 ALDH1A1 (1.00) ALDH1A1MAPTBCHEGSRCA2
Isosorbide Dinitrate SCHEMBL1553054 1.00 ALDH1A1 (1.00) ALDH1A1MAPTBCHEGSRCA2
Isosorbide Dinitrate SCHEMBL29532755 1.00 ALDH1A1 (1.00) ALDH1A1MAPTBCHEGSRCA2
Isosorbide Dinitrate SCHEMBL309369 1.00 ALDH1A1 (1.00) ALDH1A1MAPTBCHEGSRCA2
Isosorbide Dinitrate SCHEMBL3008938 0.98 ALDH1A1 (0.95) ALDH1A1MAPTBCHEGSRCA2
Isosorbide Dinitrate SCHEMBL714959 0.98 ALDH1A1 (0.95) ALDH1A1MAPTBCHEGSRCA2
Isosorbide Dinitrate SCHEMBL27976716 0.96 ALDH1A1 (0.91) ALDH1A1MAPTBCHEGSRCA2
Isosorbide Dinitrate SCHEMBL28209664 0.96 ALDH1A1 (0.91) ALDH1A1MAPTBCHEGSRCA2
Isosorbide Dinitrate SCHEMBL3864281 0.94 ALDH1A1 (0.88) ALDH1A1MAPTBCHEGSRCA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 29303 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122075410-A Dry powder composition for intranasal delivery 2026-05-26 CN claimed
CN-122071607-A Aliphatic aromatic copolyester foaming composition, aliphatic aromatic copolyester foaming bead, preparation method of aliphatic aromatic copolyester foaming bead and foaming bead molded body 中国石油化工股份有限公司 2026-05-22 CN claimed
EP-4736841-A1 A MUCOADHESIVE LAYER FOR BUCCAL ADMINISTRATION OF AN ACTIVE PHARMACEUTICAL INGREDIENT IQ medical GmbH (DE) 2026-05-06 EP claimed
WO-2026090251-A1 METHODS FOR IMPROVING TREATMENT OUTCOMES IN PATIENTS UNDERGOING ULTRAFILTRATION PROLETARIAT THERAPEUTICS, INC. (US) 2026-04-30 WO claimed
US-20260115188-A1 METHODS OF TREATING CENTERAL NERVOUS SYSTEM DISORDERS COMPRISING ADMINISTERING DEUTERATED LUMATEPERONE AND A NITRIC OXIDE DONOR INTRA-CELLULAR THERAPIES, INC. (US) 2026-04-30 US claimed
EP-3934654-B1 ISTAROXIME OR ITS METABOLITE PST-3093 FOR USE AS INTRAVENOUS FORMULATION FOR THE TREATMENT OF ACUTE HEART FAILURE (AHF) WINDTREE THERAPEUTICS INC (US) 2026-04-29 EP claimed
EP-4734213-A1 ELECTROLYTE FOR LITHIUM-SULFUR BATTERY LG Energy Solution, Ltd. (KR) 2026-04-29 EP claimed
US-12605345-B2 Transdermal drug delivery system BioPhysics Pharma, Inc. (US) 2026-04-21 US claimed
US-20260102373-A1 LYMPH DIRECTING PRODRUGS MONASH UNIVERSITY (AU) 2026-04-16 US claimed
EP-4724049-A1 MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF Catalent Ontario Limited (CA) 2026-04-15 EP claimed
US-4346709-A Drug delivery devices comprising erodible polymer and erosion rate modifier ALZA CORPORATION (US) 1982-08-31 US claimed
US-4299727-A Disposable reversible thermometer AKZONA INCORPORATED (US) 1981-11-10 US claimed
US-4293565-A Transdermal medication system for isosorbide dinitrate SANOL SCHWARZ-MONHEIM GMBH (DE) 1981-10-06 US claimed
EP-0036138-A2 Composition of matter for topical application comprising a bio-affecting agent and N,N-diethyl-m-toluamide MERCK & CO. INC. (US) 1981-09-23 EP claimed
US-4267138-A Coating ensuring a controlled release of active ingredients of biologically active compositions, particularly pharmaceutical compositions and a process for preparation of biologically active compositions ensuring controlled release of active ingredients RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 1981-05-12 US claimed
EP-0001566-B1 CYCLOBUTANECARBOXYLIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS INSECTICIDES BAYER AG (DE) 1980-11-26 EP claimed
US-4156736-A Supersaturated isosorbide dinitrate solution, process for its production and its use SANOL SCHWARZ-MONHEIM GMBH (DE) 1979-05-29 US claimed
US-4112115-A Therapy of leg muscle cramps COGHLAN CHARLES C 1978-09-05 US claimed
US-RE29076-E DRUG, CELLULOSE, MANNITOL, MAGNESIUM STEARATE, DEXTROSE, CORN SYRUP IVES LABORATORIES INC. (US) 1976-12-14 US claimed
US-RE29077-E CELLULOSE, MAGNESIUM STEARATE IVES LABORATORIES INC. (US) 1976-12-14 US claimed